<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Han D</submitter><funding>NHLBI NIH HHS</funding><funding>Miriam and Sheldon G. Adelson Medical Research Foundation</funding><funding>National Institutes of Health</funding><pagination>1257-1263</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8527330</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(11)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>Aortic valve calcification (AVC) has been shown to be associated with increased cardiovascular disease (CVD) risk; however, whether this is independent of traditional risk factors and coronary artery calcification (CAC) remains unclear.&lt;h4>Methods and results&lt;/h4>From the multicentre CAC Consortium database, 10 007 patients (mean 55.8±11.7 years, 64% male) with concomitant CAC and AVC scoring were included in the current analysis. AVC score was quantified using the Agatston score method and categorized as 0, 1-99, and ≥100. The endpoints were all-cause, CVD, and coronary heart disease (CHD) deaths. AVC (AVC>0) was observed in 1397 (14%) patients. During a median 7.8 (interquartile range: 4.7-10.6) years of study follow-up, 511 (5.1%) deaths occurred; 179 (35%) were CVD deaths, and 101 (19.8%) were CHD deaths. A significant interaction between CAC and AVC for mortality was observed (P&lt;0.001). The incidence of mortality events increased with higher AVC; however, AVC ≥100 was not independently associated with all-cause, CVD, and CHD deaths after adjusting for CVD risk factors and CAC (P=0.192, 0.063, and 0.206, respectively). When further stratified by CAC&lt;100 or ≥100, AVC ≥100 was an independent predictor of all-cause and CVD deaths only in patients with CAC &lt;100, after adjusting for CVD risk factors and CAC [hazard ratio (HR): 1.93, 95% confidence interval (CI): 1.14-3.27; P=0.013 and HR: 2.71, 95% CI: 1.15-6.34; P=0.022, respectively].&lt;h4>Conclusion&lt;/h4>Although the overall prognostic significance of AVC was attenuated after accounting for CAC, high AVC was independently associated with all-cause and CVD deaths in patients with low coronary atherosclerosis burden.</pubmed_abstract><journal>European heart journal. Cardiovascular Imaging</journal><pubmed_title>Prognostic significance of aortic valve calcium in relation to coronary artery calcification for long-term, cause-specific mortality: results from the CAC Consortium.</pubmed_title><pmcid>PMC8527330</pmcid><funding_grant_id>L30 HL110027</funding_grant_id><pubmed_authors>Rumberger JA</pubmed_authors><pubmed_authors>Gransar H</pubmed_authors><pubmed_authors>Nasir K</pubmed_authors><pubmed_authors>Budoff MJ</pubmed_authors><pubmed_authors>Miedema MD</pubmed_authors><pubmed_authors>Blumenthal RS</pubmed_authors><pubmed_authors>Berman DS</pubmed_authors><pubmed_authors>Rozanski A</pubmed_authors><pubmed_authors>Dardari Z</pubmed_authors><pubmed_authors>Cordoso R</pubmed_authors><pubmed_authors>Blaha MJ</pubmed_authors><pubmed_authors>Shaw LJ</pubmed_authors><pubmed_authors>Han D</pubmed_authors><pubmed_authors>Whelton S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic significance of aortic valve calcium in relation to coronary artery calcification for long-term, cause-specific mortality: results from the CAC Consortium.</name><description>&lt;h4>Aims&lt;/h4>Aortic valve calcification (AVC) has been shown to be associated with increased cardiovascular disease (CVD) risk; however, whether this is independent of traditional risk factors and coronary artery calcification (CAC) remains unclear.&lt;h4>Methods and results&lt;/h4>From the multicentre CAC Consortium database, 10 007 patients (mean 55.8±11.7 years, 64% male) with concomitant CAC and AVC scoring were included in the current analysis. AVC score was quantified using the Agatston score method and categorized as 0, 1-99, and ≥100. The endpoints were all-cause, CVD, and coronary heart disease (CHD) deaths. AVC (AVC>0) was observed in 1397 (14%) patients. During a median 7.8 (interquartile range: 4.7-10.6) years of study follow-up, 511 (5.1%) deaths occurred; 179 (35%) were CVD deaths, and 101 (19.8%) were CHD deaths. A significant interaction between CAC and AVC for mortality was observed (P&lt;0.001). The incidence of mortality events increased with higher AVC; however, AVC ≥100 was not independently associated with all-cause, CVD, and CHD deaths after adjusting for CVD risk factors and CAC (P=0.192, 0.063, and 0.206, respectively). When further stratified by CAC&lt;100 or ≥100, AVC ≥100 was an independent predictor of all-cause and CVD deaths only in patients with CAC &lt;100, after adjusting for CVD risk factors and CAC [hazard ratio (HR): 1.93, 95% confidence interval (CI): 1.14-3.27; P=0.013 and HR: 2.71, 95% CI: 1.15-6.34; P=0.022, respectively].&lt;h4>Conclusion&lt;/h4>Although the overall prognostic significance of AVC was attenuated after accounting for CAC, high AVC was independently associated with all-cause and CVD deaths in patients with low coronary atherosclerosis burden.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2024-11-12T21:43:43.475Z</modification><creation>2022-02-11T14:45:01.352Z</creation></dates><accession>S-EPMC8527330</accession><cross_references><pubmed>33331631</pubmed><doi>10.1093/ehjci/jeaa336</doi></cross_references></HashMap>